By JoAnne Keatley, MSW, Director and Co-Principal Investigator, Center of Excellence for Transgender Health at the University of California San Francisco
JoAnne Keatley, MSW, Director and Co-Principal Investigator, Center of Excellence for Transgender Health at the University of California San Francisco
November has been designated as the National Transgender Awareness Month in order to raise awareness of issues that affect the transgender (trans) community. November 20th is the National Transgender Remembrance Day, an opportunity for the trans community and its allies to stand up against the lack of legal and workplace protection from discrimination and the transphobic violence that threatens daily life. For example, trans youth are harassed and bullied in schools or worse. In Oakland, my own backyard, a 16 year old was set on fire on a municipal bus traveling home from school merely for being their authentic self, because they were assigned a male sex at birth and had dared to wear a skirt and use gender neutral pronouns. This is terrible, heart breaking, and tragic.
By Anna Carroll, Associate, Global Program, NASTAD
NASTAD Haiti staff celebrate NASTAD’s 10th Anniversary Commemoration at our office in Port-au-Prince.
In 2003, a small cohort of NASTAD technical assistance providers visited Port-au-Prince, Haiti to explore the possibility of providing support to the Haiti Ministry of Health (MoH) as it developed its HIV surveillance system. Over the following years, NASTAD partnered with the MoH to design, pilot, and implement one of the few, high-functioning case surveillance systems in the developing world. Today, after ten years of successful collaboration, NASTAD Haiti has an office in Port-au-Prince staffed by 10 local public health practitioners, and has expanded its work to support not only HIV case based surveillance but also enhanced perinatal surveillance of HIV-positive pregnant women and their HIV-exposed babies, and surveillance of HIV/TB co-infection.
FOR IMMEDIATE RELEASE
Contact: Murray Penner
October 28, 2013, Washington, DC – The ADAP Crisis Task Force (Task Force) announced today that it has reached agreement with Bristol-Myers Squibb (BMS) and Boehringer Ingelheim (BI) to extend voluntary discounts/rebates and price freezes to all state AIDS Drug Assistance Programs (ADAPs). The continuation of existing agreements beyond 2013 will provide stability to ADAPs as they continue to navigate the uncharted terrain of a reformed health system as a result of implementation of the Affordable Care Act (ACA) and continued fiscal challenges at both the state and federal level.
The Task Force, convened by the National Alliance of State and Territorial AIDS Directors (NASTAD), previously secured continuation through 2014 of existing agreements for voluntary discounts and rebates from AbbVie, Gilead Sciences, Janssen Therapeutics, Merck and ViiV Healthcare. Many of these agreements also provide continued price freezes for ADAPs for varying lengths of time into 2014 and 2015. Continue reading
By Meico Whitlock, Senior Manager, Communications, NASTAD
Cross-posted from AIDS.gov
Last month, the National Alliance of State and Territorial AIDS Directors
(NASTAD) attended the fourth annual Plain Talk in Complex Times conference
in Arlington, Virginia. This year’s theme was “Communicating in a Time of Change.” The conference was hosted by the MAXIMUS Center for Health Literacy
in collaboration with the American Public Health Association
(APHA) and brought together leaders and decision-makers in fields such as public health, health communications, digital media, usability, accessibility, translation, interpretation, readability, design, and plain language to discuss communicating effectively with health consumers.
Sessions covered a range of topics such as writing for mobile device users, providing high quality care to linguistically diverse populations, and communicating effectively with numbers. A number of sessions also focused specifically on technology and provided helpful tips for tasks such conducting low-cost usability testing, enhancing website accessibility, producing podcasts, and graphic design for print materials. Continue reading
By Anna Carroll, Associate, Global Program, NASTAD
NASTAD staff visit the Hlalanikahle Clinic with Mpumalanga Department of Health Staff, the Health Facility Manager and Facility Based Support Group Facilitators
Since 2002, the number of people receiving antiretroviral therapy (ART) for HIV/AIDS in low- and middle-income countries has increased dramatically, from 300,000 in 2002 to 9.7 million in 2012. Despite this striking improvement, this represents only 34% of people currently eligible for ART under the 2013 WHO guidelines.
The National Alliance of State and Territorial AIDS Directors (NASTAD) Global Program has worked hard to reduce this massive treatment gap in South Africa, where an estimated 5.6 million people are living with HIV and AIDS, the greatest number of people in any country worldwide. In 2009, the South African government initiated the Integrated Access to Care and Treatment (I ACT) Program as one important component of its national response to the HIV epidemic. As a primary partner to provincial departments of health in South Africa, NASTAD began working in partnership with the Free State and Mpumalanga Provincial Departments of Health (PDoH) to support the implementation and development of I ACT in these provinces. Continue reading